QuidelOrtho Full Year 2023 Earnings: Misses Expectations

QuidelOrtho (NASDAQ:QDEL) Full Year 2023 Results

Key Financial Results

• Revenue: US$3.00b (down 8.2% from FY 2022).
• Net loss: US$10.1m (down by 102% from US$548.7m profit in FY 2022).
• US$0.15 loss per share (down from US$9.66 profit in FY 2022).

All figures shown in the chart above are for the trailing 12 month (TTM) period

QuidelOrtho Revenues and Earnings Miss Expectations

Revenue missed analyst estimates by 1.5%. Earnings per share (EPS) was also behind analyst expectations.

Looking ahead, revenue is forecast to stay flat during the next 3 years compared to a 7.8% growth forecast for the Medical Equipment industry in the US.

Performance of the American Medical Equipment industry.

The company's shares are down 2.9% from a week ago.

Risk Analysis

We should say that we've discovered 2 warning signs for QuidelOrtho (1 is a bit unpleasant!) that you should be aware of before investing here.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.